R. Ferguson

4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors.

F. Fiorentini, M. Brasca, F. Roletto, 2010, Bioorganic & medicinal chemistry letters.

Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores.

S. Xu, B. Priest, P. Morissette, 2017, Bioorganic & medicinal chemistry letters.

The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diuretics.

J. Metzger, K. Maloney, E. Joshi, 2017, Bioorganic & medicinal chemistry letters.

434 POSTER Antitumoral activity of pyrazoloquinazoline derivatives as potent oral Plk-1 specific inhibitors

M. Brasca, E. Pesenti, M. Rocchetti, 2008 .

Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.

D. Ballinari, V. Croci, D. Volpi, 2010, Journal of medicinal chemistry.

Development of a 9-borabicyclo[3.3.1]nonane-mediated solid-phase Suzuki coupling for the preparation of dihydrostilbene analogs

Roger A. Smith, Ning Su, R. Ferguson, 2003 .

Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.

E. Casale, E. Felder, A. Galvani, 2013, Bioorganic & medicinal chemistry.

Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90).

A. Isacchi, E. Casale, E. Felder, 2013, Bioorganic & medicinal chemistry.